AMERICAN SHARED HOSPITAL SERVICES (NYSE MKT:AMS), a
leading provider of turnkey technology solutions for advanced
radiosurgical and radiation therapy services, announced today that the
Centers for Medicare and Medicaid Services (CMS) has posted its final
Medicare hospital outpatient prospective payment rates for calendar year
2014.
Effective January 1, 2014, CMS Gamma Knife delivery code reimbursement
will be increased to $3,592 from the previous rate of $3,301, a 9%
increase. It is estimated that including ancillary services and outlier
adjustments, if applicable, Gamma Knife centers can receive Medicare
reimbursement of up to around $9,000 per treatment under the recently
announced CMS rates.
CMS’s 2014 proton therapy delivery code rates per daily session are $872
($1,137 in 2013) for a simple treatment and $1,205 ($682 in 2013) for an
intermediate or complex treatment.
About AMS
American Shared Hospital Services provides turnkey technology solutions
for advanced radiosurgical and radiation therapy services. AMS is the
world leader in providing Gamma Knife radiosurgery equipment, a
non-invasive treatment for malignant and benign brain tumors, vascular
malformations and trigeminal neuralgia (facial pain). The Company also
offers the latest IGRT and IMRT systems, as well as its proprietary
Operating Room for the 21st CenturySM concept. AMS owns
common stock in Mevion Medical Systems, Inc., developer of the compact
MEVION S250 Proton Therapy System.
Safe Harbor Statement
This press release may be deemed to contain certain forward-looking
statements with respect to the financial condition, results of
operations and future plans of American Shared Hospital Services, which
involve risks and uncertainties including, but not limited to, the risks
of the Gamma Knife and radiation therapy businesses. Further
information on potential factors that could affect the financial
condition, results of operations and future plans of American Shared
Hospital Services is included in the filings of the Company with the
Securities and Exchange Commission, including the Company's Annual
Report on Form 10-K for the year ended December 31, 2012, the Quarterly
Report on Form 10-Q for the quarters ended on March 31, 2013,June 30,
2013, and September 30, 2013, and the definitive Proxy Statement for the
Annual Meeting of Shareholders held on June 11, 2013.
Copyright Business Wire 2013